Medifast Inc expected to post a loss of 28 cents a share - Earnings Preview

Reuters11-02

* Medifast Inc is expected to show a fall in quarterly revenue when it reports results on November 4 for the period ending September 30 2024

* The Owings Mills Maryland-based company is expected to report a 43.1% decrease in revenue to $134.15 million from $235.87 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.The company's guidance on August 5 2024, for the period ended September 30, was for revenue between $125.00 million and $145.00 million.

* ​LSEG's mean analyst estimate for Medifast Inc is for a loss of 28 cents per share. The company's EPS guidance on August 5 2024, for the period ended September 30, was between $-0.70 and $-0.05

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell."

* The mean earnings estimate of analysts was unchanged in the last three months. ​

* Wall Street's median 12-month price target for Medifast Inc is 17.25​, below​ its last closing price of $18.58. ​​​

This summary was machine generated November 2 at 03:50 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment